Guggenheim Reiterates Buy Rating on Bruker (BRKR)
Guggenheim analyst Subbu Nambi reiterated a Buy rating and $70.00 price target on Bruker (NASDAQ: BRKR).The analyst commented: "After the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
